Verbeek MWC, Buracchi C, Laqua A, Nierkens S, et al. Flow cytometric minimal residual disease assessment in B-cell precursor acute lymphoblastic leukaemia patients treated with CD19-targeted therapies - a EuroFlow study. Br J Haematol 2022;197:76-81.
PMID: 34881427